Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Jun. 30, 2020
CURRENT ASSETS
Cash	$ 11,620	$ 15,282
Prepaid expenses and other assets	14,995	13,361
Tax refunds receivable	737	3,317
Accounts receivable, net	25,152	9,858
Note receivable, related party	2,066	6,878
Total Current Assets	54,570	48,696
Property and Equipment, Net	1,405	1,922
Operating lease right-of-use asset	70,349	74,710
TOTAL ASSETS	126,324	125,328
LIABILITIES
Accounts payable and accrued expenses	135,140	119,246
Accrued interest - related party	57,343	42,359
Notes payable - related party	745,962	618,568
Current portion of operating lease liability	13,743	11,312
Total Current Liabilities	952,188	791,485
Operating lease liability, net of current portion	57,390	63,721
Total Liabilities	1,009,578	855,206
STOCKHOLDERS' DEFICIT
Preferred stock, no par value; 10,000,000 shares authorized, -0- shares issued and outstanding	0	0
Common stock, no par value; 250,000,000 shares authorized 203,355,598 and 203,355,598 shares issued and 203,301,842 and 203,301,842 shares outstanding respectively	33,027,676	33,027,676
Additional paid-in capital	4,513,328	4,513,328
Treasury stock, at cost	(19,387)	(19,387)
Accumulated other comprehensive income	90,454	91,907
Accumulated deficit	(37,845,291)	(37,696,425)
Total Sangui Biotech International, Inc's stockholders' defict	(233,220)	(82,901)
Non-controlling interest	(650,034)	(646,977)
Total Stockholders' Deficit	(883,254)	(729,878)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 126,324	$ 125,328